Skip to main content
OpenTrials
Completed

NCT Number: NCT04373863

Assessment of Lifestyle, Blood Pressure, Cholesterol and Glycated Hemoglobin in a Specific Population

The project Shall we get to know your health better? Lifestyle assessment, blood pressure and cholesterol in the population of Libbs Farmacêutica employeesLTDA.; consists of a study that will bring knowledge and enable quantificationof risk factors related to cardiovascular diseases in this population above mentioned.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cholesterol; Lipidosis Arterial Hypertension Behavior Blood Glucose, High Cardiovascular Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Genetic Diseases, Inborn Hypertension Lipid Metabolism Disorders Lipid Metabolism, Inborn Errors Lipidoses Metabolic Diseases Metabolism, Inborn Errors Nutritional and Metabolic Diseases Smoking Vascular Diseases

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Augusto Theodoro de Figueiredo

São Paulo, 01140050, Brazil

About this study

The social relevance of this study is related to the knowledge and quantification of eating habits and lifestyles related to cardiovascular diseases in the population of employees, also referred to in this document as "employees", from Libbs Farmacêutica Ltda. Based on an observation and statistical analysis of the data obtained in this study, internal policies will be promoted that aim to improve eating habits, physical activity and decrease smoking.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being an employee Libbs Farmacêutica Ltda;

Exclusion criteria

  • not applicable

Treatment and study plan

Primary outcomes

  1. Descriptive questionnaire

    Time frame: until December 2020

    Descriptive information about lifestyle and family history and through exams, blood pressure and serum cholesterol values in the population of Libbs Farmacêutica Ltda employees.

Secondary outcomes

  1. Prevalence of hypercholesterolemia and arterial hypertension

    Time frame: until December 2020

    Quantify the prevalence of hypercholesterolemia (serum total cholesterol above 200mg / dL - worst case) and hypertension (systolic blood pressure above 140mmHg or diastolic blood pressure above 90mmHg - worst case)

  2. Glycated hemoglobin (HbA1c) values

    Time frame: until December 2020

    Track the glycated hemoglobin (HbA1c) values of the research participants, in order to know the average blood glucose levels in the last 3 months before the day of the exam and quantify the prevalence of participants who have HbA1c above the value considered normal in literature, which is up to 5.6% (best scenario)

  3. Data correlation

    Time frame: until December 2020

    • Correlate eating habits with socioeconomic characteristics;
    • Correlate the values of serum cholesterol, blood pressure and glycated hemoglobin with eating habits, level of physical activity practiced and prevalence of smoking

Sponsors and collaborators

Lead sponsor

Libbs Farmacêutica LTDA

Industry

Registry information

Official study title

Let's Get to Know Your Health Better? Assessment of Lifestyle, Blood Pressure and Cholesterol in the Population of Employees Libbs Farmacêutica LTDA.

Acronym: LB1901

Important dates

Study start
2020
Primary completion
2021
Study completion
2023
First posted
May 5, 2020
Registry last updated
Oct 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.